STK25 and colorectal cancer: LIM domain kinase 1 (LIMK1), a novel β-catenin kinase highly expressed in colorectal cancer and associated with poor prognosis, promotes malignant progression through its interaction with STK25, which enhances cell proliferation and metastasis [38].